Valeant's thinking about shedding some assets

Valeant Pharmaceuticals is thinking about selling some of its skin and cancer drugs, according to Bloomberg.

More on this to come…

NOW WATCH: These are the best, highest-paying companies in America

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at